Oldenlandia diffusa ameliorates dextran sulphate sodium-induced colitis through inhibition of NF-κB activation

American Journal of Chinese Medicine

Volumn 39, Issue 5, 2011, Pages 957-969

  Kim, Su Jin ^a,b   Kim, Yang Gui ^b   Kim, Dae Seung ^c   Jeon, Yong Deok ^c   Kim, Min Cheol ^c   Kim, Hye Lin ^b   Kim, Seon Young ^b   Jang, Hyeung Jin ^b   Lee, Byung Cheol ^b   Hong, Seung Heon ^c   Um, Jae Young ^b  

^a Daegu Haany University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Cyclooxygenase 2; Dextran Sulfate Sodium; Interleukin 6; Nuclear Factor B; Oldenlandia diffusa; Ulcerative Colitis

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; HENTRIACONTANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; OLDENLANDIA DIFFUSA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; MEDICINAL PLANT; MOUSE; NONHUMAN; OCCULT BLOOD; OLDENLANDIA; OLDENLANDIA DIFFUSA; ULCERATIVE COLITIS; WEIGHT REDUCTION;

ANIMALS; COLITIS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; OLDENLANDIA; PLANT EXTRACTS;

EID: 80052643418     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009330     Document Type: Article

References (40)

1. Agoff, S.N., T.A. Brentnall, D.A. Crispin, S.L. Taylor, S. Raaka, R.C. Haggitt, M.W. Reed, I.A. Afonina, P.S. Rabinovitch, A.C. Stevens, Z. Feng and M.P. Bronner. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am. J. Pathol. 157: 737-745, 2000. (Pubitemid 32109366)
2. Ardizzone, S. and P.G. Bianchi. Biologic therapy for inflammatory bowel disease. Drugs 65: 2253-2286, 2005. (Pubitemid 41571985)
3. Barnes, P.J. and M. Karin. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071, 1997. (Pubitemid 27163860)
4. Blackwell, T.S. and J.W. Christman. The role of nuclear factor-kB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17: 3-9, 1997. (Pubitemid 127500814)
5. Blumberg, R.S., L.J. Saubermann and W. Strober. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11: 648-656, 1999.
6. Bouma, G. and W. Strober. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533, 2003. (Pubitemid 37328672)
7. Danese, S., M. Sans and C. Fiocchi. Inflammatory bowel disease; the role of environmental factors. Autoimmun. Rev. 3: 394-400, 2004. (Pubitemid 38993362)
8. Dharmappa, K.K., R.V. Kumar, A. Nataraju, R. Mohamed, H.V. Shivaprasad and B.S. Vishwanath. Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med. 75: 211-215, 2009.
9. Domenech, E. Inflammatory bowel disease: Current therapeutic options. Digestion 73: 67-76, 2006.
10. Fiocchi, C. Inflammatory bowel disease; etiology and pathogenesis. Gastroenterology 115: 182-205, 1998. (Pubitemid 28307304)
11. Gabay, O., C. Sanchez, C. Salvat, F. Chevy, M. Breton, G. Nourissat, C. Wolf, C. Jacques and F. Berenbaum. Stigmasterol: A phytosterol with potential anti-osteoarthritic properties. Osteoarthr. Cartil. 18: 106-116, 2010.
12. Gupta, S., D. Zhang, J. Yi and J. Shao. Anticancer activities of Oldenlandia diffusa. J. Herb Pharmacother. 4(1): 21-33, 2004. (Pubitemid 38495766)
13. Hendrickson, B.A., R. Gokhale and J.H. Cho. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev. 15: 79-94, 2002. (Pubitemid 34052583)
14. Huang, Y., D. Nikolic, S. Pendland, B.J. Doyle, T.D. Locklear and G.B. Mahady. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro. Pharm. Biol. 47: 18-25, 2009.
15. Hyams, J.S. Inflammatory bowel disease. Pediatr. Rev. 21: 291-295, 2000.
16. Ishiguro, K., T. Ando, O. Maeda, M. Hasegawa, K. Kado-matsu, N. Ohmiya, Y. Niwa, R. Xavier and H. Goto. Paeonolattenuates TNBS-induced colitis by inhibiting NF-αB and STAT1 transactivation. Toxicol. Appl. Pharmacol. 217: 35-42, 2006. (Pubitemid 44635657)
17. Jeong, H.J., H.J. Na, S.H. Hong and H.M. Kim. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 144: 4080-4086, 2003.
18. Kim, E.C., Y. Zhu, V. Andersen, D. Sciaky, H.J. Cao, H. Meekins, T.J. Smith and P. Lance. Cytokine-mediated PGE2 expression in human colonic fibroblasts. Am. J. Physiol. 275: 988-994, 1998.
19. Li, Y., C. de Haar, M. Chen, J. Deuring, M.M. Gerrits, R. Smits, B. Xia, E.J. Kuipers and J. van der Woude. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 59: 227-235, 2010.
20. Lin, T.Y., Y.C. Liu, J.R. Jheng, H.P. Tsai, J.T. Jan, W.R. Wong and J.T. Horng. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am. J. Chin. Med. 37: 143-158, 2009.
21. MacDonald, T.T. and S.H. Murch. Aetiology and pathogenesis of chronicin flammatory bowel disease. Baillieres Clin. Gastroenterol. 8: 1-34, 1994. (Pubitemid 24133108)
22. Murthy, S.N., H.S. Cooper, H. Shim, R.S. Shah, S.A. Ibarahim and D.J. Sedergran. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38: 1722-1734, 1993. (Pubitemid 23271431)
23. Neurath, M.F., S. Pettersson, K.H. Meyer zum Buschenfelde and W. Strober. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NFkappaB abrogates established experimental colitis in mice. Nat. Med. 2: 998-1004, 1996. (Pubitemid 26306838)
24. Ogata, H. and T. Hibi. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharm. Des. 9: 1107-1113, 2003. (Pubitemid 36443211)
25. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki and R. Nakaya. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990. (Pubitemid 20069706)
26. Papadakis, K.A. and S.R. Targan. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298, 2000. (Pubitemid 30216038)
27. Roberts, P.J., K. Morgan, R. Miller, J.O. Hunter and S.J. Middleton. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48: 468-472, 2001. (Pubitemid 32234789)
28. Rogler, G. and T. Andus. Cytokines in inflammatory bowel disease. World J. Surg. 22: 382-389, 1998. (Pubitemid 28113526)
29. Rogler, G., K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P.A. Baeuerle, J. Schölmerich and V. Gross. Nuclear factor-B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 537-569, 1998.
30. Rufo, P.A. and A. Bousvaros. Currenttherapy of inflammatory bowel disease in children. Paediatr. Drugs 8: 279-302, 2006. (Pubitemid 44607534)
31. Russel, M.G. and R.W. Stockbrügger. Epidemiology of inflammatory bowel disease: An update. Scand. J. Gastroenterol. 31: 417-427, 1996. (Pubitemid 26153633)
32. Sandborn, W.J. and S.R. Targan. Biologic therapy of inflammatory bowel disease. Gastroenterology 122: 1592-1608, 2002. (Pubitemid 34533555)
33. Sato, K., S. Ohkura, Y. Kitahara, T. Ohama, M. Hori, M. Sato, S. Kobayashi, Y. Sasaki, T. Hayashi, T. Nasu and H. Ozaki. Involvement of CPI-17 downregula in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model. Neurogastroenterol. Motil. 19: 504-514, 2007. (Pubitemid 46905395)
34. Schaecher, K., J.M. Goust and N.L. Banik. The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: Identification of the calpain cleavage sites Neurochem. Res. 29: 1443-1451, 2004. (Pubitemid 39011333)
35. Stevens, C., G. Walz, C. Singaram, M.L. Lipman, B. Zanker, A. Muggia, D. Antonioli, M.A. Peppercorn and T.B. Strom. Tumor necrosis factor-a, interleukin-1, and interleukin-6 expression in inflammatory bowel disease. Dig. Dis. Sci. 37: 818-826, 1992.
36. Tak, P.P. and G.S. Firestein. NF-αB: A key role in inflammatory disease. J. Clin. Invest. 107: 7-11, 2001. (Pubitemid 32047405)
37. Takahashi, C., N. Kikuchi, N. Katou, T. Miki, F. Yanagida and M. Umeda. Possible anti-tumourpromoting activity of components in Japanese soybean fermented food, natto: Effect on gap junctional intercellular communication. Carcinogenesis 16: 471-476, 1995.
38. Talhouk, R.S., C. Karam, S. Fostok, W. El-Jouni and E.K. Barbour. Anti-inflammatory bioactivities in plant extracts. J. Med. Food. 10: 1-10, 2007. (Pubitemid 46706842)
39. Ullman, T., V. Croog, N. Harpaz, D. Sachar and S. Itzkowitz. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125: 1311-1319, 2003. (Pubitemid 37409751)
40. Zheng, P., F. Niu, W. Liu, Y. Shi and L. Lu. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitisofrats. World J. Gastroenterol. 11: 4912-4915, 2005. (Pubitemid 41223310)